AMLS Module 5: Nosocomial Pneumonia

Module 5 of our AMR Life Support Course (AMLS). This module is an interactive lecture on nosocomial pneumonia.

Target Audience

This activity is specifically designed for clinicians, healthcare providers, and AMR stewards to address AMR at the hospital.

Learning Objectives

At the end of the module, learners should be able to:

Define hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
Distinguish between true infection from colonization, and review relevant microbiology and likely resistance patterns.
Discuss empiric therapy, how to adjust treatment once culture results are available, appropriate durations of therapy, and prevention strategies.

Module Outline

This module will take approximately 1 hour to complete.

Introduction & Clinical Framework
Clinical Vignette 1: Hospital-Acquired Pneumonia (HAP)
Clinical Vignette 2: Ventilator-Associated Pneumonia (VAP)
Integration and Stewardship Principles

Course Directors

Dr. Carl Boodman, MD, FRCPC, DTM&H, CTropMed® is a Canadian infectious diseases physician, a medical microbiologist and a PhD Candidate at the Institute of Tropical Medicine/ University of Antwerp (Belgium). He is a Clinical Investigator Program Candidate at the University of Manitoba (Canada) and a member of the International Diagnostics Network.

Dr. Nitin Gupta, MBBS, MD, DM, DTM&H, CTropMed, DipRCPath, AAHIVS, PGPE, FRSPH, CIC, MTM - Associate Professor, Infectious Diseases, Kasturba Medical College, Manipal, India Coordinator, Centre for Tropical Febrile Illness, MAHE, Manipal, India.